Impact Of Hypoglycemia

There is little published information about the clinical impact of hypoglycemia in type 2 diabetes. While it is reasonable to extrapolate from the experience in type 1 diabetes, there are obvious differences. As noted earlier, episodes of hypoglycemia become familiar events early in the course of type 1 diabetes. They are infrequent early in the course of type 2 diabetes, even during treatment with insulin secretagogues or insulin, but become progressively more frequent as the patient approaches the insulin-deficient end of the spectrum of type 2 diabetes (12,13). Furthermore, while type 2 diabetes occurs in all age groups including children, most affected people are middle aged and older and, therefore, at higher risk of erratic food ingestion and even malnutrition, co-morbid conditions and drug interactions, impaired drug metabolism and renal insufficiency with reduced insulin clearance. They are also more susceptible to macrovascular events because of underlying cardiovascular disease.

Iatrogenic hypoglycemia causes both physical morbidity (and some mortality) and psychosocial morbidity (6). While estimates of hypoglycemic mortality rates in type 2 diabetes are not available, deaths caused by sulfonylurea-induced hypoglycemia (like insulin-induced hypoglycemia) are well documented (14). The mortality of a given episode of severe sulfonylurea-induced hypoglycemia has been reported to be as high as 10% (14,15). The physical morbidity of an episode of hypoglycemia ranges from unpleasant neurogenic (autonomic) symptoms, such as sweating, hunger, palpitations, tremor and anxiety, to neuroglycopenic manifestations. The latter range from cognitive impairments and behavioral changes to seizures and coma (and rarely death). Transient focal neurological deficits occur occasionally. While seemingly complete neurological recovery is the rule following an episode of hypoglycemia, prolonged severe hypoglycemia can cause permanent neurological damage. The extent to which the latter might be more frequent in older individuals with type 2 diabetes is unknown.

At the very least, an episode of hypoglycemia is a nuisance and a distraction; it can be embarrassing and lead to social ostracism. The psychological morbidity includes fear of hypoglycemia, guilt about that rational fear, high levels of anxiety and low levels of overall happiness. Fear of hypoglycemia can be an impediment to glycemic control. Thus, hypoglycemia is often a psychological, as well as a pathophysiological, barrier to glycemic control. The performance of critical tasks, such as driving, is measurably impaired during hypoglycemia, as is judgment. Finally, the demands of the management of diabetes, including the prevention of both hyperglycemia and hypoglycemia, become progressively more obtrusive over time in type 2 diabetes, albeit over a longer time span than in type 1 diabetes.

Getting to Know Anxiety

Getting to Know Anxiety

Stop Letting Anxiety Rule Your Life And Take Back The Control You Desire Right Now! You don't have to keep letting your anxiety disorder run your life. You can take back your inner power and change your life for the better starting today! In order to have control of a thing, you first must understand it. And that is what this handy little guide will help you do. Understand this illness for what it is. And, what it isn't.

Get My Free Ebook


Post a comment